Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Neuro-Oncological Ventral Antigen 1 (NOVA1) Peptid

NOVA1 Wirt: Synthetic BP, WB, IHC
Produktnummer ABIN5615032
  • Target Alle NOVA1 Produkte
    NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
    Quelle
    • 5
    Synthetic
    Applikation
    Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
    Sequenz
    TNGYFGAASP LAASAILGTE KSTDGSKDVV EIAVPENLVG AILGKGGKTL
    Produktmerkmale
    A synthetic peptide for use as a blocking control in assays to test for specificity of NOVA1 antibody, catalog no. 70R-5002
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Buffer
    Lyophilized powder. Add 100 μL of distilled water for a final peptide concentration is 1 mg/mL.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20 deg C long term. Avoid repeat freeze-thaw cycles.
  • Target
    NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
    Synonyme
    Nova-1 Peptide, NOVA1 Peptide, si:ch211-222c22.9 Peptide, 9430099M15Rik Peptide, G630039L02 Peptide, NOVA alternative splicing regulator 1 Peptide, neuro-oncological ventral antigen 1 L homeolog Peptide, neuro-oncological ventral antigen 1 Peptide, RNA-binding protein Nova-1 Peptide, lipid A export ATP-binding/permease protein Peptide, NOVA1 Peptide, Nova1 Peptide, nova1.L Peptide, nova1 Peptide, LOC790874 Peptide, novA1 Peptide
Sie sind hier:
Kundenservice